Thread: Patient taking Novartis MS pill developed rare disease (Yahoo)
View Single Post
Old 07-30-2013, 09:20 AM
NewsBot NewsBot is offline
News Gatherer
Community Support Team
  
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Default Patient taking Novartis MS pill developed rare disease (Yahoo)
ZURICH (Reuters) - A patient taking Novartis' multiple sclerosis pill Gilenya developed a rare and potentially fatal viral disease, the Swiss drugmaker said on Tuesday, an unexpected setback as it faces growing competition from new oral treatments. Gilenya is one of Novartis' big new drug hopes, growing 66 percent in the second quarter to $468 million. But the drug faces competition from new medicines such as Biogen Idec's Tecfidera. Novartis said it had been informed of a case of progressive multifocal leukoencephalopathy (PML) in a patient who had been taking Gilenya for MS for seven months. ...




Read the full article...

(From Yahoo Diseases)
NewsBot is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
ANNagain (07-30-2013), barb02 (08-01-2013), Kitty (07-30-2013), tkrik (07-30-2013)